Rapidly evolving consumer markets in cities such as Shanghai, the growth of e-commerce and policy support under the Healthy China 2030 initiative, are reinforcing Bayer's confidence in the country's consumer health market. The German company sees China as both a key growth engine and a source of innovation, and is committed to investing for the long term, a senior executive said.